Literature DB >> 16799611

The treatment of mastocytosis: an overview.

D D Metcalfe1.   

Abstract

The treatment of mastocytosis requires a recognition of specific disease patterns of involvement, with consequent institution of appropriate therapy based on the disease pattern manifested in a given patient. Treatment for most forms of mastocytosis is conservative and symptomatic. H1 and H2 antihistamines in combination or alone remain the primary drugs of choice. In specific cases, patients may require aspirin and/or steroids; some must be prepared to self-administer epinephrine for severe anaphylactic episodes. In patients with associated hematologic disorders, the treatment of the disorder will depend on the hematologic findings. In rare cases, and in aggressive forms of mastocytosis only, it may be necessary to consider limited forms of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 16799611     DOI: 10.1111/1523-1747.ep12469049

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

Review 1.  Mastocytosis and disorders of mast cell proliferation.

Authors:  Joanne K Simpson; Dean D Metcalfe
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  Mastocytosis: update on pharmacotherapy and future directions.

Authors:  Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal:  Expert Opin Pharmacother       Date:  2013-10       Impact factor: 3.889

Review 3.  Unconventional uses of common conventional drugs: A review.

Authors:  Anupam Das; Abheek Sil; Shouvik Ghosh; Saumya Panda
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jul-Aug       Impact factor: 2.545

Review 4.  Insights in Anaphylaxis and Clonal Mast Cell Disorders.

Authors:  David González-de-Olano; Iván Álvarez-Twose
Journal:  Front Immunol       Date:  2017-07-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.